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1. Introduction 
Being the only exocrine organ located in the midline, the prostate gland is a compound 
tubuloalveolar exocrine gland of the male reproductive system, locating just below the 
bladder. The term “prostate” comes (as commonly published) from Greek prostates, literally 
which means “someone who stands before someone or something’’ that is ‘‘president’’ or 
‘‘principal’’ ; however in  a recent paper on history of medical terminology it was suggested 
that in fact the term was originating from Greek parastates which means literally ‘‘someone 
who stands next to someone or something’’ or ‘‘companion’’ and was transformed into 
prostates due to misspelling and misinterpretation [1].  
Embryologically, the prostate develops from the endodermal urogenital sinus which is an 
ambisexual embryonic rudiment.  Endodermal urogenital sinus forms the prostate, prostatic 
urethra and bulbourethral glands in the males and the lower vagina and urethra in the 
females. The embryonic connective tissue surrounding endodermal urogenital sinus is 
called urogenital sinus mesenchyme. Under the influence of fetal androgens, epithelial 
outgrowths from the wall of the urogenital sinus move into the surrounding urogenital 
sinus mesenchyme forming prostatic glandular structure and the surrounding mesenchyme 
differentiates into smooth muscle cells and fibroblasts [2]. The secretory epithelium in this 
compound tubuloalveolar gland structure is mainly pseudostratified with transitional 
epithelium in the distal regions of the longer ducts. In the prostate gland acini, small round 
luminal hyaline masses called corpora amylacea may be found. With average diameter of 
0.25 mm, pink–purple to orange color these masses are believed to be related to epithelial 
cell desquamation and degeneration. They are composed of bundles of fibrils and 
containing mainly sulfated glycosaminoglycans [3].  Corpora amylacea are frequently seen 
in the benign acini of prostates of adult men however, they are rarely seen in prostate 
carcinoma [4].   
2. Prostate stones: Formation and structure 
In the literature, sometimes prostatic calculi are classified as either primary /endogenous 
calculi (developing within the acini of the gland) or secondary/exogenous (upper urinary 
system stone found in the prostatic urethra). Throughout this chapter, the terms “prostatic 
calculi” or “prostate stone” refers only to the stones developing within the acini of the gland 
(primary /endogenous calculi). 
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The calcification of corpora amylacea within gland acini forms prostate stones. Prostate 
stones are predominantly found in the cephalic portion of the posterior lobe and in the 
larger ducts and acini of the lateral lobes of the prostate. Those within the acini are 
microscopic,while those within the ducts tend to be larger and are visible grossly. Suggested 
mechanism of the stone formation is the intra-prostatic reflux of urine which causes the 
deposition of hydroxyapatite crystallites in corpora amylacea and mineralization with 
calcium, leading to the formation of calculi [5–7]. Obstruction of the acini with calculi causes 
dilatation of acini and further increase in size of the stone with further precipitation of 
crystals. As well, the growing calculi itself or together with the inflammatory process, that it 
may initiate, may occlude other acini causing further stone formation. This way of formation 
leads to concentric calcification layers in the stone which is clearly seen under scanning 
electron microscope [8] (Figure 1). Such an occlusion mechanism might be responsible in 
cases of benign prostate hyperplasia. Observation of prostate stones located in the 
compressed true prostate adjacent to the adenomatous mass also supports this mechanism 
[9]. Prostate stones are not infection stones. Major calcium components of prostate stone are 
calcium phosphate or calcium oxalate, along with carbonate-apatite and hydroxyapatite 
[7,8,10].  
  
Fig. 1. Concentric calcification layers of prostate stone under scanning electron microscope  
(Personal archive of Koseoglu H, MD.) 
Also, some pathological conditions like alkaptonuria and vitamin D overdose have been 
reported to cause prostatic calculi [11,12]. 
Prostate stones were classified structural morphology and mineral composition [13,14]  In 
one older study, stones taken from males with BPH were analyzed with scanning electron 
microscopy and energy dispersive type X-ray microanalyzer (EDAX) system for structure 
and element compositions. Mainly, elements of Na, Al, Mg, S, P, Ca and Zn were identified. 
Stones were classified as type I and type II. Type I prostate stones have lobular surface made 
up of small spheres containing predominantly of sodium, sulfur, phosphorus, calcium, and 
zinc. Type II prostate stones have polyfaceted surface composed primarily of calcium 
phosphate in the form of hydroxyapatite crystals with high peaks of P and Ca [13]. In a 
rather recent study, the fine structure and mineral components prostate stones were 
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analyzed by scanning electron microscopy, backscattered electron (BSE) imaging, energy-
dispersive X-ray (EDX) microanalysis under an SEM and X-ray diffraction [14]. Main 
element composisiton was Ca,P,Mg, Zn and S.  The prostate stones were classified into four 
groups (I–IV). Group I had the core deposits of calcospherites showing concentric rings and 
the laminated apatite deposits concentrically around the core. Group II had calcospherite 
deposits of apatite similar to group I with a rougher concentric formation. Group III similar 
to group I had the core of calcospherites and concentric laminated structures with wider 
peripheral region containing calcium oxalates spikes. Gorup IV had the core deposits with 
small hexahedral structures, identified as whitlockite, surrounded by incompletely 
concentric laminated bands of apatite. Group I–III were suggested to form from 
mineralization of corpora amylacea whereas group IV was suggested to form from 
mineralization of  the organic substances, which might be derived from the simple 
precipitation of prostatic secretion [14]. 
Other than the crytalline structure of the prostate stones, their protein composition was 
studied with infrared spectroscopy and high-performance liquid chromatography combined 
with tandem mass spectrometry (LC/MS/MS) in the prostate stones taken form radical 
prostatectomy specimen of prostate cancer patients [15]. The predominant crystalline 
component was also  confirmed as calcium phosphate in the form of hydroxyapatite. The 
most prevalent proteins were lactoferrin, myeloperoxidase, and S100 calcium-binding 
proteins A8 and A9. Others were multiple proteins found in neutrophil granules. All these 
proteins act in acute inflammatory pathways. The authors suggested that this may indicate 
past inflammatory events in the prostate [15]. 
3. Epidemiology  
The data in the literature on the prevalence of prostatic calculi is inconclusive.  In a report of 
postmortem study using microradiographic examination, the intraprostatic calcifications 
were found to be prevalent as high as 71% [16].  In one study using transrectal 
ultrasonography prostatic calculi were detected in 198 (40.7%) of the 486 screened man with 
a mean age of 61.9 +/- 0.4 years (range 29 to 89) [17].  In another study using transrectal 
ultrasonography prostatic calculi were detected in 799 (51.1%) of 1563 with a younger mean 
age of 49.5 +/- 5.4 years (range 40 to 59) [18].  Again, in another study done with transrectal 
ultrasonography prostatic calculi were detected with a similar ratio of 41.77 % [19].   
However, in another recent study using transabdominal ultrasonography (TRUS only in 
16.83% of cases) the prevalence was found to be low as 7.35% in a screened adult group with 
a mean age of  40.9 (range 21–50) years [20].  The methodological difference may be a reason 
of low prevalence. But, in that study the patients were chosen among a population of 
nonconsecutive 1374 young men that attended the hospital outpatient clinics for several 
reasons. It is worthy to note that in other studies using transrectal ultrasonography, above 
mentioned, the study population was chosen from consecutive patients attending urology 
clinics for routine checkup of PSA and DRE evaluation or with complaints of LUTS or 
chronic prostatitis/chronic pelvic pain syndrome. That may also be a reason for the high 
difference between prevalence of the studies. 
The youngest patient reported was 4 year old and in that patient the calculi was thought to 
be related to vitamin D overdose [11]. 
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4. Clinical importance  
Prostate stones are generally clinically asymptomatic, when symptomatic the symptoms are 
generally related to lower urinary tract symptoms [18,19].  The prostatic calculi are mostly 
found incidentally during diagnostic workup for any urological complaint. In the CT scans, 
pelvic/transrectal ultrasonography or KUB X-scans they may be found incidentally  
(Figures 2; 3). They are also frequently encountered during transurethral resection of the 
prostate [8] (Figure 4). In benign prostatic hyperplasia, prostate stones tend to be located in the 
compressed true prostate, adjacent to the adenomatous mass [9]. Therefore, during 
transurethral resection of the prostate, prostate stones are rather observed when the depth of 
resection increased and thus they act sometimes as a border for prostate capsule during TURP.  
 
Fig. 2. Pelvic ultrasonography showing prostate stone in the prostate gland (Personal 
archive of Koseoglu H, MD.) 
The presence of large prostatic calculi has been shown to be a significant associated factor of 
moderate LUTS [18]. In another study, patients with prostate stones were reported to have 
more severe LUTS and decreased the maximum urinary flow rates compared to patients 
without prostate stones. However, based on multivariate analyses, prostate stone was not an 
independent predictive factor of severe LUTS [19]. Rather, older age and larger prostate 
volume were independent predisposing factors for prostate stone [19].  
Larger prostate stones were suggested to have a relation with clinical prostatitis/ chronic 
pelvic pain syndrome [20]. Histopathological inflammation with varying degrees of severity 
may accompany prostate stones [8]. However, it is unclear whether inflammation is a cause 
or the result of calculi formation. The prostatic stones do not raise PSA, which increases with 
inflammation, indirectly indicating that these calculi do not increase inflammation [17].   On 
the other hand, intra-prostatic reflux related to prostate stone formation may play a role in 
the accompanying inflammation of prostate gland. In a study using anti-nanobacterial agent 
it was shown that prostatic stones diminished 50% ultrasonographically and chronic 
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prostatitis symptom scores were decreased [21]. However, there was no relationship 
between chronic prostatitis symptom scores and prostatic calculi or level of the histological 
prostatic inflammation [21].    
 
Fig. 3. Pelvic CT scan showing prostate stone in the prostate gland ( Personal archive of 
Koseoglu H, MD.) 
 
Fig. 4. Prostate stones encountered during TUR-P ( Personal archive of Koseoglu H, MD.) 
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In the literature, there are few case reports related to large prostate stones causing 
infravesical obstruction [22-27].  
No direct or indirect relationship has been reported between prostate stone and prostate 
cancer. Actually the incidence of corpora amylacea in adenocarcinoma is low [5]. 
5. Management of prostate stones 
Though prostate stones are generally accepted as clinically silent,  few cases were reported 
to have surgical intervention for severe obstruction caused by large prostate stones. Surgical 
procedures like open transvesical prostate stone extraction [23], endoscopic extraction 
[12,22,25], open prostatolithotomy [26] and even radical prostatectomy [27] have been 
performed to extract these stones.  
As mentioned above ,in one study anti-nanobacterial agent was studied in patients with 
chronic prostatitis and prostate stones and it was shown that  prostate stones diminished 
50% ultrasonographically [21]. But, yet this is to be clarified by further studies.  
6. Summary 
In the prostate gland acini, the small round luminal hyaline masses are called corpora 
amylacea and their calcifications form prostate stones.  Suggested mechanism is the intra-
prostatic reflux of urine which causes the deposition of hydroxyapatite crystallites in 
corpora amylacea and mineralization with calcium. Some pathological conditions like 
alkaptonuria and vitamin D overdose have been reported to cause prostatic calculi. Major 
calcium components of prostate stone are calcium phosphate or calcium oxalate, along with 
carbonate-apatite and hydroxyapatite, whereas most prevalent proteins are lactoferrin, 
myeloperoxidase, and S100 calcium-binding proteins A8 and A9.  Being predominantly 
located in the cephalic portion of the posterior lobe and in the larger ducts and acini of the 
lateral lobes of the prostate, prostate stones are mostly clinically asymptomatic.  When it is 
symptomatic the symptoms are generally related to lower urinary tract symptoms. Few 
cases with large prostate stones causing infravesical obstruction and necessitating surgical 
intervention have been reported. No direct or indirect relationship has been reported 
between prostate stone and prostate cancer.  
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